Overview
This clinical trial was prospective, randomized, single-blind, 3-treatment arm, parallel treatment group, and active-controlled. , Multi-center, Phase 3 confirmatory clinical trial.
Eligibility
Inclusion Criteria:
- Patients who is informed and give a consent in voluntary
- Patients who is scheduled a esophagogastroduodenoscopy and colonoscopy
- BMI 19≤and<30
Exclusion Criteria:
- Patients who participate in other interventional study or had participated within 30 days before screening
- Pregnant or breast-feeding women who do not want to stop breast-feeding
- Uncontrolled hypertension
- Uncontrolled diabetes
- Fluid or electrolyte (Na, K, Ca, Mg, chloride, bicarbonate) disturbance
- HIV infection and/or chronic hepatitis B or C
- Patients who has a difficulty to participate because of severe nausea or vomiting
- History of colon surgery and abdominal surgery within 6 month; need an emergency surgery